Global Insight in Cancer Incidence, Mortality, and Disparities

Recent releases of cancer statistics from global agencies and national registries have provided a rather detailed and, at times, surprisingly dynamic view of how the cancer burden is shifting worldwide. The overall picture remains dominated by a steady rise in incidence, now surpassing 19 million new cases globally in 2022, while mortality approaches 10 million. At the same time, long-term improvements in high-income countries continue, especially in the United States, where more than four million deaths have been prevented since 1991. Yet these encouraging trends sit uneasily alongside emerging concerns, including rising incidence in younger adults, widening racial and regional disparities, and the long tail of diagnostic disruptions during the COVID-19 pandemic. Drawing on statistical reports from GLOBOCAN, CA: A Cancer Journal for Clinicians, population-based registries in Japan and Taiwan, and related epidemiological analyses, this review summarizes the major cancer trends observed from 2022 through 2025 and reflects on their implications for prevention, screening, and public health policy.